Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00176_DB00752_nanopub.RAr3Gd6NVkiuQySXTH5gMzMbBhXE_8uQXMxkbSATw3AcA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00176_DB00752 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00176_DB00752 label "DDI between Fluvoxamine and Tranylcypromine - Increased risk of serotonin syndrome. Concomitant therapy should be avoided. A significant washout period, dependent on the half-lives of the agents, should be employed between therapies. [drugbank_resource:DB00176_DB00752]" assertion.
- drugbank_resource:DB00176_DB00752 identifier "drugbank_resource:DB00176_DB00752" assertion.
- drugbank_resource:DB00176_DB00752 title "DDI between Fluvoxamine and Tranylcypromine - Increased risk of serotonin syndrome. Concomitant therapy should be avoided. A significant washout period, dependent on the half-lives of the agents, should be employed between therapies." assertion.
- drugbank:DB00752 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00176_DB00752 assertion.
- drugbank:DB00176 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00176_DB00752 assertion.